Zimmer Biomet device gets FDA approval

Zimmer Biomet Holdings Inc. said it has completed its first surgical case using a new device called a comprehensive augmented baseplate, which offers an alternative to bone grafting for patients with defects in the shoulder cavity who are undergoing shoulder reconstruction.

The Warsaw-based maker of orthopedic devices said the first surgery was recently performed at the Mayo Clinic. The device was approved by the U.S. Food and Drug Administration in January.

The company—formed by the $13 billion merger of Zimmer Holdings Inc. and Biomet Inc.—is among the world’s largest makers of orthopedic medical devices. It reported $7.8 billion in sales last year.•